ID: ALA2336387

Max Phase: Preclinical

Molecular Formula: C14H22N8O

Molecular Weight: 318.39

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)n1cnc2c(NC(=N)N)nc(OC[C@H]3CCCN3)nc21

Standard InChI:  InChI=1S/C14H22N8O/c1-8(2)22-7-18-10-11(19-13(15)16)20-14(21-12(10)22)23-6-9-4-3-5-17-9/h7-9,17H,3-6H2,1-2H3,(H4,15,16,19,20,21)/t9-/m1/s1

Standard InChI Key:  KGKVLKDXPJRNHF-SECBINFHSA-N

Associated Targets(Human)

Aurora kinase A/B 33 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 2/cyclin E1 1877 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 1/cyclin B1 1887 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 318.39Molecular Weight (Monoisotopic): 318.1917AlogP: 0.84#Rotatable Bonds: 5
Polar Surface Area: 126.76Molecular Species: BASEHBA: 7HBD: 4
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.33CX LogP: 0.89CX LogD: -2.33
Aromatic Rings: 2Heavy Atoms: 23QED Weighted: 0.48Np Likeness Score: -0.27

References

1. Dolečková I, Cesnek M, Dračinský M, Brynda J, Voller J, Janeba Z, Kryštof V..  (2013)  Synthesis and biological evaluation of guanidino analogues of roscovitine.,  62  [PMID:23399722] [10.1016/j.ejmech.2013.01.021]

Source